Assignee
LIFEEDIT THERAPEUTICS INC
US·7 granted patents·10 pending applications·13 citations·filing 2019–2024
Top patents by PatentIndex Score
17 records- 0195US11981916B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·2 cites·38 claims
- 0295US11162114B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·11 cites·19 claims
- 0390US12252718B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 0489US12252706B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·28 claims
- 0587US2025066783A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0685US2024026384A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0783US11981940B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·0 cites·18 claims
- 0883US11859181B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted Jan 2, 2024·0 cites·18 claims
- 0980US2023175018A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1077US11926843B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·0 cites·28 claims
- 1172US2022145296A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1266US2026069715A1Compositions and methods for the treatment of huntingtons disease by editing the mutant huntingtin geneLIFEEDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1360US2024271162A1Rna polymerase iii promoters and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1459US2024301385A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2023203463A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1655US2024247242A1Uracil stabilizing proteins and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1755US2022364074A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LIFEEDIT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →